Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Single studies aren't enoughI want to see multiple trials, ideally in humans, with consistent results
Drug Safety 2024;47:439451
2022 R&D Spend: For the year ended March 31, 2023, Daiichi Sankyo spent 341.57 billion JPY ($2.60 billion USD) on R&D, a 31.21 percent increase from the 260.33 billion JPY ($2.37 billion USD) the company spent on R&D for the year ended March 31, 2022
doi: 10.1159/000496426 182 MalhotraN.GerT
US$ 23.16
US$ 23.61
US$ 29.27
US$ 27.12
US$ 28.68
US$ 23.45
US$ 29.07
